InMed Pharmaceuticals (INM) Other Working Capital Changes (2021 - 2025)
Historic Other Working Capital Changes for InMed Pharmaceuticals (INM) over the last 5 years, with Q3 2025 value amounting to -$129992.0.
- InMed Pharmaceuticals' Other Working Capital Changes rose 6047.28% to -$129992.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$231005.0, marking a year-over-year increase of 4788.63%. This contributed to the annual value of -$429880.0 for FY2025, which is 816.71% down from last year.
- InMed Pharmaceuticals' Other Working Capital Changes amounted to -$129992.0 in Q3 2025, which was up 6047.28% from -$114659.0 recorded in Q2 2025.
- Over the past 5 years, InMed Pharmaceuticals' Other Working Capital Changes peaked at $1.2 million during Q1 2022, and registered a low of -$918075.0 during Q2 2024.
- In the last 5 years, InMed Pharmaceuticals' Other Working Capital Changes had a median value of -$129992.0 in 2025 and averaged -$92619.4.
- In the last 5 years, InMed Pharmaceuticals' Other Working Capital Changes skyrocketed by 32081.95% in 2022 and then crashed by 74161.43% in 2024.
- Quarter analysis of 5 years shows InMed Pharmaceuticals' Other Working Capital Changes stood at -$212964.0 in 2021, then surged by 320.82% to $470266.0 in 2022, then skyrocketed by 90.95% to $897962.0 in 2023, then crashed by 86.09% to $124943.0 in 2024, then crashed by 204.04% to -$129992.0 in 2025.
- Its last three reported values are -$129992.0 in Q3 2025, -$114659.0 for Q2 2025, and -$111297.0 during Q1 2025.